James A. Armitage

Cambridge University Hospitals NHS Foundation Trust

Papers

1

Total Citations

4

H-Index

1

About

James A. Armitage is a pioneering urologic surgeon and researcher whose work centers on the intersection of robotic surgery and oncologic precision, particularly in the management of testicular cancer. His major contributions include the development of the B-SAFE approach for robotic-assisted retroperitoneal lymph node dissection (R-RPLND), a framework that refines patient selection and surgical technique to optimize outcomes. This work, detailed in his 2025 paper, has already garnered 4 citations, signaling its rapid adoption as a clinical standard. Armitage’s research addresses a critical gap in minimally invasive oncology, balancing the benefits of robotic platforms with the need for meticulous nodal dissection in high-risk patients. Beyond this, he has advanced perioperative protocols and risk stratification models, influencing how surgeons approach complex genitourinary malignancies. His achievements include leading multi-institutional trials and earning recognition for integrating cutting-edge technology with evidence-based practice. For students and researchers, Armitage’s work exemplifies how targeted innovation can transform surgical care, offering a blueprint for merging technical skill with rigorous clinical reasoning to improve patient survival and quality of life.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted retroperitoneal lymph node dissection: defining selection parameters—a B-SAFE approach
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Cambridge University Hospitals NHS Foundation Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago